Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

1.8%

13 terminated/withdrawn out of 724 trials

Success Rate

90.2%

+3.7% vs industry average

Late-Stage Pipeline

12%

85 trials in Phase 3/4

Results Transparency

4%

5 of 120 completed trials have results

Key Signals

192 recruiting5 with results9 terminated4 withdrawn

Enrollment Performance

Analytics

N/A
235(44.3%)
Phase 2
152(28.6%)
Phase 4
44(8.3%)
Phase 3
41(7.7%)
Phase 1
41(7.7%)
Early Phase 1
18(3.4%)
531Total
N/A(235)
Phase 2(152)
Phase 4(44)
Phase 3(41)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (724)

Showing 20 of 724 trials
NCT06284642Phase 4Recruiting

Early Lumbar Drainage Plus Intrathecal Urokinase in Severe Aneurysmal Subarachnoid Hemorrhage (LD-ITUK)

Role: collaborator

NCT05491811Phase 2Active Not Recruiting

Ensartinib in Combination With Bevacizumab in ALK-positive NSCLC Patients With TP53 Mutation

Role: collaborator

NCT07563543Early Phase 1Not Yet Recruiting

RN1701 Injection in the Treatment of Relapsed/Refractory B-Cell Lymphomas

Role: lead

NCT06817954Not ApplicableRecruiting

To Evaluate the Effectiveness and Safety of Mastectomy Combined With Immediate Breast Reconstruction in Breast Cancer (NJMU-Reconstruction Cohort)

Role: lead

NCT07558863Phase 4Recruiting

Effect of GLP-1RA on Cardiac Autonomic Neuropathy in Type 2 Diabetes

Role: lead

NCT07558850Not ApplicableRecruiting

Exploratory Clinical Study of Anti-CD19/BCMA Universal CAR-T Cell Injection for the Treatment of Refractory Autoimmune Diseases

Role: lead

NCT07533825Not ApplicableEnrolling By Invitation

Laparoscopic Staging for Stage III Gastric Cancer

Role: collaborator

NCT07438106Phase 2Recruiting

A Phase II Study of HRS-4642 Combined With AG (Nab-paclitaxel and Gemcitabine) as Conversion Therapy for Locally Advanced Pancreatic Cancer

Role: lead

NCT07530549Phase 2Not Yet Recruiting

A Phase II Single-arm Clinical Study in the Treatment of Locally Advanced Esophageal Cancer After Failed Neoadjuvant Chemoimmunotherapy

Role: collaborator

NCT06759636Phase 3Recruiting

A Study on the Treatment of CTIT of the Efficacy and Safety With Romiplostim N01 Compared to Recombinant Human Interleukin-11

Role: lead

NCT07523789Not Yet Recruiting

Comparison of Chemotherapy and Immunotherapy in Neoadjuvant Therapy for TNBC

Role: lead

NCT06968936Not ApplicableRecruiting

Long-term Outcomes Sub-Study of Preoperative Combined Iron Therapy

Role: collaborator

NCT07377981Phase 4Not Yet Recruiting

An Exploratory Study of the Efficacy and Safety of Esketamine and Dexmedetomidine in Non-Intubated ICU Patients With Hyperactive Delirium: Protocol of a Randomized Controlled Trial

Role: lead

NCT06790810Completed

Observational Study on Dynamic Changes of Blood Pressure During Post-epileptic Seizure Stage (OCBPS)

Role: collaborator

NCT07232095Phase 4Recruiting

7-Day Vonoprazan, High-Dose Amoxicillin, and Bismuth Therapy

Role: lead

NCT07483372Phase 1Recruiting

Safety and Efficacy of SC101 Via Perirenal Fat Injection for Resistant Hypertension in Patients With Moderate to Severe Chronic Kidney Disease

Role: lead

NCT06126081Not ApplicableActive Not Recruiting

Clinical Efficacy of Early Left Bundle Branch Pacing for Cardiac Resynchronization Therapy

Role: collaborator

NCT07482826Not ApplicableNot Yet Recruiting

Full-Endoscopic Decompression vs. Endoscopic Lumbar Fusion for Middle-Aged and Older Adults With Spinal Stenosis

Role: lead

NCT07394387Phase 2Recruiting

Neoadjuvant Study of HIFU With or Without PD-1 Inhibitors Followed by Abraxane Plus Carboplatin in Triple-Negative Breast Cancer.

Role: lead

NCT07277439Phase 2Recruiting

Phase II Trial of Neoadjuvant Thymalfasin, PD-1 Inhibitor, and Chemoradiotherapy for cStage III GEJ Adenocarcinoma

Role: lead